Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era

Objective/Background: Relapse is the most common cause of treatment failure after allogeneic hematopoietic cell transplantation (alloHCT). No standard of care exists, and a wide range of treatments are used for post-alloHCT relapse. In the recent era, several novel therapies including targeted agent...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sanghee Hong, Lisa Rybicki, Donna Corrigan, Betty K. Hamilton, Ronald Sobecks, Matt Kalaycio, Aaron T. Gerds, Rob M. Dean, Brian T. Hill, Brad Pohlman, Deepa Jagadeesh, Faiz Anwer, Navneet S. Majhail
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Allogeneic stem cell transplantation
Post-transplant relapse
Relapse
Survival
Diseases of the blood and blood-forming organs
RC633-647.5
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/7a57caab7c1048adaf808b1df5de420c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/7a57caab7c1048adaf808b1df5de420c

Documents similaires